Two enzymes that play a role in cancer mutation offer potential new targets for intervention strategies, researchers report.

When enzymes go rogue, they can cause a range of diseases, including cancers. A new platform could reveal molecules that target them.

Joining three teams backed by a total of $75 million, MIT researchers will tackle some of cancer’s toughest challenges.

Social media may help people spot melanoma early, research shows. "It's the only cancer that you can look and see with your own eyes."

Changes that cause the skin to stiffen and become less elastic may also contribute to higher rates of metastatic melanoma in older people.

Identifying proteins that are only present in bodily fluids when a patient has breast cancer could provide a way to screen healthy people for the disease.

With the new technique, MIT researchers hope to identify mutations that could be targeted with new cancer therapies.

The technology could offer a cheap, fast way to test for PFAS, which have been linked to cancer and other health problems.

New research potentially offers a new treatment alternative for brain cancer patients who currently have a poor prognosis.

Stimulating gamma brain waves may protect cancer patients from memory impairment and other cognitive effects of chemotherapy.